Article Sidebar

Published
Sep 29, 2022
Download
pdf
Statistic
Read Counter : 822 Download : 664

Main Article Content

Abstract

Pulmonary tuberculosis is a disease caused by Mycobacterium tuberculosis. Treatment for tuberculosis patients is given in the intensive and advanced stages. Anti-tuberculosis drugs can be nephrotoxic to cells in the kidneys. This research is an analytic observational study to know the comparison of urea and creatinine levels in pulmonary tuberculosis patients in the 0 and 6-month treatment phases at the Community Lung Health Center Purwokerto. The samples studied were 42 respondents who were taken by accidental sampling. This study was conducted from December 2021 to January 2022. Out of the 42 pulmonary tuberculosis patients who received treatment at 0 and 6 months, the majority of pulmonary tuberculosis patients were 28 patients (66.7%) had normal urea levels, and 38 patients (90.5 %) had normal creatinine levels. Urea levels in pulmonary tuberculosis patients during the 0-month treatment phase were 9 (2-24) mg/dL, while in the 6-month treatment phase, it was 8 (1-37) mg/dL. The creatinine level of pulmonary tuberculosis patients with 0-month treatment phase was 0.98 (0.64-1.62) mg/dL, while in the 6-month treatment phase it was 0.88 (0.62-1.92) mg/dL. There was no significant comparison of urea and creatinine levels in pulmonary tuberculosis patients with treatment phases 0 and 6 months (p>0.05).

Keywords

creatinin pulmonary tuberculosis treatment phase urea

Article Details

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite
Aprianto, A., Sudarsono, T., Kusuma Wardani, D., & Rahaju, M. (2022). Comparison of Ureum and Creatinine Levels in Patients with Pulmonary Tuberculosis in the Treatment Phase 0 and 6 Months. Jurnal Ilmu Dan Teknologi Kesehatan, 10(1), 14-24. https://doi.org/10.32668/jitek.v10i1.927

References

    Ariffriana, D., Taher, E. and Wahidah, N.I. (2016) Kimia Klinik. Edited by EGC. Jakarta.

    Denrison P and Erdiana G (2019) ‘Analisa Kadar Kreatinin Darah pada Penderita TB Paru yang Telah Mengkonsumsi Obat Anti Tuberkulosis Lebih dari 4 Bulan Di Upt Kesehatan Paru Masyarakat Medan’, Analis Laboratorium Medik, 4(2), pp. 40–45.

    Djasang, S. and Saturiski, M. (2019) ‘Studi Hasil Pemeriksaan Ureum dan Asam Urat pada Penderita Tuberkulosis Paru yang Mengonsumsi Obat Anti Tuberkulosis(OAT) Fase Intensif’, Jurnal Media Analis Kesehatan, 10(1), pp. 59–71.

    Harison, M.F. (2019) ‘Gambaran Kadar Ureum dan Kreatinin pada Penderita Tuberkulosis Paru yang Mendapat Terapi Obat Anti Tuberkolosis (OAT) di RS. Khusus Paru di RS. Khusus Paru Provinsi Sumatera Selatan Tahun 2019’, in Politeknik Kesehatan Palembang.

    Indrasari, D.N. (2015) ‘Perbedaan Kadar Ureum dan Kreatinin pada Pasien Gagal Ginjal Kronik Berdasarkan Lama Menjalani Terapi Hemodialisa di RS Muhammadiyah Yogyakarta’, Aisyiyah Health Science College of Yogyakarta, pp. 1–12.

    Kemenkes, R. (2018) Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis.

    Nihayati, H.E. et al. (2019) ‘An Effect of Breath Dhikr on the Stress Level of Patients with Pulmonary Tuberculosis’, Indian Journal of Public Health Research & Development, 10(8), pp. 6–11.

    Perdina, N. et al. (2017) ‘Gambaran abnormalitas organ hati dan ginjal pasien’, Kesehatan Kartika, 12(April 2017), pp. 1–2.

    PRATIWI, R.M. (2015) ‘Perbedaan Kadar Ureum Kreatinin Sebelum dan Sesudah Pemberian Obat Anti Tuberkulosis Fase Awal’, Universitas Muhammadiyah Yogyakarta, 022.

    Priyanto, I., Budiwiyono, I. and Suci, N. (2018) ‘Hubungan Kadar Kreatinin dengan Formula HUGE (Hematocrit, Urea, Gender) pada Pasien Penyakit

    Ginjal Kronik’, Media Medika Muda, 3(2), pp. 1–6.

    Rampa, E., Rini Prastyawati and Sinaga, H. (2019) ‘Pemeriksaan Kadar Ureum dan Kreatinin Pasien HIV yang Mendapatkan Terapi ARV di Puskesmas Harapan Sentani Kabupaten Jayapura Papua Ester Rampa’, Jurnal Penelitian Kesehatan Suara Forikes, 10(3), pp. 223–226.

    Suryawan, D.G.A., Arjani, I.A.M.S. and I G Sudarmanto (2016) ‘Gambaran Kadar Ureum Dan Kreatinin Serum pada Pasien Gagal Ginjal Kronis yang Menjalani Terapi Hemodialisis di RSUD Sanjiwani Gianyar’, Meditory, 4(1), pp. 145–153.

    Wahdaniah, Arsyad M. Aryadi, S.N. (2017) ‘The Level of Cystatin C as the Early Marker of Kidney Function Upset in Tuberculosis Patients with’, JST Kesehatan, 7(2), pp. 171–177.

    WHO (2022) ‘Global tuberculosis report 2021: supplementary material’.

    Widyanti Tuti, Rasiyanto Effendy, Anita, M.V. (2021) ‘Studi Literatur Gambaran Hasil Pemeriksaan Ureum pada Penderita Tubercolosis (TB) Paru yang Mengonsumsi Obat Anti Tuberkulosis (OAT)’, Journal of Health Science Technology, 2(1), pp. 49–56.